{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T02:46:49Z","timestamp":1794538009544,"version":"4.9.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,12,8]],"date-time":"2023-12-08T00:00:00Z","timestamp":1701993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,12,8]],"date-time":"2023-12-08T00:00:00Z","timestamp":1701993600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>To investigate the efficacy of fertility-preserving treatment for young women with synchronous primary neoplasm of endometrium and ovary.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We retrospectively reviewed eight patients with concurrent primary grade 1 presumed stage IA endometrioid endometrial adenocarcinoma (EEA) or endometrial atypical hyperplasia (EAH) and primary stage I ovarian tumors who underwent fertility-sparing treatment in the Obstetrics and Gynecology Hospital of Fudan University between April 2016 and December 2022.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Synchronous endometrial and ovarian cancers (SEOC) accounted for 50% of these eight patients. The median age of patients was 30.5 years (range, 28\u201334 years). None of them received chemotherapy. The median treatment time was 4 months (range, 3\u20138 months). 87.5% (7\/8) cases achieved complete response (CR), and the median time to CR was 3.8 months (range, 1.5\u20137.7 months). Among patients who got CR, none of them showed any signs of recurrence. Pregnancies and successful deliveries were achieved in 4 of 5 patients. Till September 2023, the median follow-up period was 50.5 months (range:15.2\u201385.2 months).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Fertility-sparing treatment is feasible for highly selected patients with synchronous neoplasm of the endometrium and ovary, but strict screening and monitoring are mandatory. Though the results of our limited cases are encouraging, long follow-up and more clinical data are required. Enrolled patients must be fully informed of the risks during conservative treatment.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13048-023-01316-w","type":"journal-article","created":{"date-parts":[[2023,12,8]],"date-time":"2023-12-08T02:02:03Z","timestamp":1702000923000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["The pregnancy and oncology outcome of fertility-sparing management for synchronous primary neoplasm of endometrium and ovary"],"prefix":"10.1186","volume":"16","author":[{"given":"Qujia","family":"Gama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengfei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lulu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sijia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongwei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiqin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuezhen","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,8]]},"reference":[{"issue":"2","key":"1316_CR1","doi-asserted-by":"publisher","first-page":"170","DOI":"10.6004\/jnccn.2018.0006","volume":"16","author":"WJ Koh","year":"2018","unstructured":"Koh WJ, Abu-Rustum NR, Bean S, Bradley K, Campos SM, Cho KR, et al. Uterine neoplasms, version 1.2018 clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2018;16(2):170\u201399.","journal-title":"J Natl Compr Canc Netw"},{"issue":"2","key":"1316_CR2","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.pathol.2017.10.007","volume":"50","author":"CB Gilks","year":"2018","unstructured":"Gilks CB, Kommoss F. Synchronous tumors of the female reproductive tract. Pathology. 2018;50(2):214\u201321.","journal-title":"Pathology"},{"issue":"2","key":"1316_CR3","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1006\/gyno.2001.6400","volume":"83","author":"R Zaino","year":"2001","unstructured":"Zaino R, Whitney C, Brady MF, DeGeest K, Burger RA, Buller RE. Simultaneously detected endometrial and ovarian carcinomas - a prospective clinicopathologic study of 74 cases: a gynecologic oncology group study. Gynecol Oncol. 2001;83(2):355\u201362.","journal-title":"Gynecol Oncol"},{"issue":"1","key":"1316_CR4","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.ygyno.2019.01.014","volume":"153","author":"B Yang","year":"2019","unstructured":"Yang B, Xu Y, Zhu Q, Xie L, Shan W, Ning C, et al. Treatment efficiency of comprehensive hysteroscopic evaluation and lesion resection combined with progestin therapy in young women with endometrial atypical hyperplasia and endometrial cancer. Gynecol Oncol. 2019;153(1):55\u201362.","journal-title":"Gynecol Oncol"},{"issue":"6","key":"1316_CR5","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1038\/bjc.2016.254","volume":"115","author":"R Fruscio","year":"2016","unstructured":"Fruscio R, Ceppi L, Corso S, Galli F, Dell\u2019Anna T, Dell\u2019Orto F, et al. Long-term results of fertility-sparing treatment compared with standard radical Surgery for early-stage epithelial ovarian cancer. Br J Cancer. 2016;115(6):641\u20138.","journal-title":"Br J Cancer"},{"issue":"1","key":"1316_CR6","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1093\/annonc\/mdp267","volume":"21","author":"C Uzan","year":"2010","unstructured":"Uzan C, Kane A, Rey A, Gouy S, Duvillard P, Morice P. Outcomes after conservative treatment of advanced-stage serous borderline tumors of the ovary. Ann Oncol. 2010;21(1):55\u201360.","journal-title":"Ann Oncol"},{"issue":"1","key":"1316_CR7","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.ygyno.2004.06.045","volume":"95","author":"PT Ramirez","year":"2004","unstructured":"Ramirez PT, Frumovitz M, Bodurka DC, Sun CC, Levenback C. Hormonal therapy for the management of grade 1 endometrial adenocarcinoma: a literature review. Gynecol Oncol. 2004;95(1):133\u20138.","journal-title":"Gynecol Oncol"},{"key":"1316_CR8","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/1757-2215-6-59","volume":"6","author":"D Atallah","year":"2013","unstructured":"Atallah D, Safi J, el Kassis N, Rouzier R, Chahine G. Simultaneous early ovarian and endometrial cancer treated conservatively with spontaneous pregnancy. J Ovarian Res. 2013;6:59.","journal-title":"J Ovarian Res"},{"issue":"2","key":"1316_CR9","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.ijgo.2014.02.003","volume":"125","author":"H Belhadj","year":"2014","unstructured":"Belhadj H, Berek J, Bermudez A, Bhatla N, Cain J, Denny L, et al. FIGO staging for carcinoma of the vulva, cervix, and corpus uteri. Int J Gynecol Obstet. 2014;125(2):97\u20138.","journal-title":"Int J Gynecol Obstet"},{"issue":"1","key":"1316_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ecl.2013.09.009","volume":"43","author":"SL Samson","year":"2014","unstructured":"Samson SL, Garber AJ. Metabolic syndrome. Endocrinol Metab Clin North Am. 2014;43(1):1.","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"3","key":"1316_CR11","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.ygyno.2014.01.004","volume":"132","author":"W Shan","year":"2014","unstructured":"Shan W, Ning C, Luo X, Zhou Q, Gu C, Zhang Z, et al. Hyperinsulinemia is associated with endometrial hyperplasia and disordered proliferative endometrium: a prospective cross-sectional study. Gynecol Oncol. 2014;132(3):606\u201310.","journal-title":"Gynecol Oncol"},{"issue":"7","key":"1316_CR12","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1111\/1471-0528.16108","volume":"127","author":"BY Yang","year":"2020","unstructured":"Yang BY, Gulinazi Y, Du Y, Ning CC, Cheng YL, Shan WW, et al. Metformin plus megestrol acetate compared with MA alone as fertility-sparing treatment in patients with atypical endometrial hyperplasia and well-differentiated endometrial cancer: a randomized controlled trial. BJOG. 2020;127(7):848\u201357.","journal-title":"BJOG"},{"issue":"1","key":"1316_CR13","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.ygyno.2009.09.024","volume":"116","author":"LA Cantrell","year":"2010","unstructured":"Cantrell LA, Zhou CX, Mendivil A, Malloy KM, Gehrig PA, Bae-Jump VL. Metformin is a potent inhibitor of endometrial cancer cell proliferation-implications for a novel treatment strategy. Gynecol Oncol. 2010;116(1):92\u20138.","journal-title":"Gynecol Oncol"},{"issue":"3","key":"1316_CR14","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1097\/01.AOG.0000154151.14516.f7","volume":"105","author":"PT Soliman","year":"2005","unstructured":"Soliman PT, Oh JC, Schmeler KM, Sun CC, Slomovitz BM, Gershenson DM, et al. Risk factors for young premenopausal women with endometrial cancer. Obstet Gynecol. 2005;105(3):575\u201380.","journal-title":"Obstet Gynecol"},{"issue":"5","key":"1316_CR15","doi-asserted-by":"publisher","first-page":"363","DOI":"10.3322\/caac.21565","volume":"69","author":"KD Miller","year":"2019","unstructured":"Miller KD, Nogueira L, Mariotto AB, Rowland JH, Yabroff KR, Alfano CM, et al. Cancer treatment and survivorship statistics, 2019. CA Cancer J Clin. 2019;69(5):363\u201385.","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"1316_CR16","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1097\/01.AOG.0000172423.64995.6f","volume":"106","author":"C Walsh","year":"2005","unstructured":"Walsh C, Holschneider C, Hoang Y, Tieu K, Karlan B, Cass I. Coexisting ovarian malignancy in young women with endometrial cancer. Obstet Gynecol. 2005;106(4):693\u20139.","journal-title":"Obstet Gynecol"},{"issue":"3","key":"1316_CR17","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.ygyno.2006.11.013","volume":"104","author":"AA Shamshirsaz","year":"2007","unstructured":"Shamshirsaz AA, Withiam-Leitch M, Odunsi K, Baker T, Frederick PJ, Lele S. Young patients with endometrial carcinoma selected for Conservative treatment: a need for vigilance for synchronous ovarian carcinomas, case report and literature review. Gynecol Oncol. 2007;104(3):757\u201360.","journal-title":"Gynecol Oncol"},{"issue":"1","key":"1316_CR18","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/S1028-4559(10)60019-8","volume":"49","author":"Y-H Yang","year":"2010","unstructured":"Yang Y-H, Chen R-J, Lin M-C, Cheng S-P, Chang T-C. Synchronous primary ovarian and endometrial cancer with a fair prognosis in a young woman. Taiwan J Obstet Gynecol. 2010;49(1):97\u2013100.","journal-title":"Taiwan J Obstet Gynecol"},{"issue":"2","key":"1316_CR19","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1093\/humupd\/dms047","volume":"19","author":"E Darai","year":"2013","unstructured":"Darai E, Fauvet R, Uzan C, Gouy S, Duvillard P, Morice P. Fertility and borderline ovarian tumor: a systematic review of conservative management, risk of recurrence and alternative options. Hum Reprod Update. 2013;19(2):151\u201366.","journal-title":"Hum Reprod Update"},{"issue":"10","key":"1316_CR20","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1200\/JCO.2009.24.8617","volume":"28","author":"T Satoh","year":"2010","unstructured":"Satoh T, Hatae M, Watanabe Y, Yaegashi N, Ishiko O, Kodama S, et al. Outcomes of fertility-sparing surgery for stage I epithelial ovarian cancer: a proposal for patient selection. J Clin Oncol. 2010;28(10):1727\u201332.","journal-title":"J Clin Oncol"},{"issue":"4","key":"1316_CR21","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1097\/AOG.0b013e31819c7bdf","volume":"113","author":"MG Williams","year":"2009","unstructured":"Williams MG, Bandera EV, Demissie K, Rodriguez-Rodriguez L. Synchronous primary ovarian and endometrial cancers: a population-based assessment of survival. Obstet Gynecol. 2009;113(4):783\u20139.","journal-title":"Obstet Gynecol"},{"issue":"3","key":"1316_CR22","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.ygyno.2017.09.027","volume":"147","author":"K Matsuo","year":"2017","unstructured":"Matsuo K, Machida H, Frimer M, Marcus JZ, Pejovic T, Roman LD, et al. Prognosis of women with stage I endometrioid endometrial cancer and synchronous stage I endometrioid ovarian cancer. Gynecol Oncol. 2017;147(3):558\u201364.","journal-title":"Gynecol Oncol"},{"issue":"5","key":"1316_CR23","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1097\/IGC.0000000000000971","volume":"27","author":"V Jain","year":"2017","unstructured":"Jain V, Sekhon R, Pasricha S, Giri S, Modi KB, Shrestha E, et al. Clinicopathological characteristics and prognostic factors of synchronous endometrial and ovarian cancers-a single-Institute review of 43 cases. Int J Gynecol Cancer. 2017;27(5):938\u201346.","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"1316_CR24","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1136\/ijgc-2020-002230","volume":"31","author":"N Concin","year":"2021","unstructured":"Concin N, Matias-Guiu X, Vergote I, Cibula D, Mirza MR, Marnitz S, et al. ESGO\/ESTRO\/ESP guidelines for the management of patients with endometrial carcinoma. Int J Gynecol Cancer. 2021;31(1):12\u201339.","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"1316_CR25","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/S0046-8177(85)80210-0","volume":"16","author":"TM Ulbright","year":"1985","unstructured":"Ulbright TM, Roth LM. Metastatic and independent cancers of the endometrium and ovary - a clinicopathologic study of 34 cases. Hum Pathol. 1985;16(1):28\u201334.","journal-title":"Hum Pathol"},{"issue":"2","key":"1316_CR26","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.ygyno.2004.05.006","volume":"94","author":"PT Soliman","year":"2004","unstructured":"Soliman PT, Slomovitz BA, Broaddus RR, Sun CC, Oh JC, Eifel PJ, et al. Synchronous primary cancers of the endometrium and ovary: a single institution review of 84 cases. Gynecol Oncol. 2004;94(2):456\u201362.","journal-title":"Gynecol Oncol"},{"issue":"1","key":"1316_CR27","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/his.13985","volume":"76","author":"L Casey","year":"2020","unstructured":"Casey L, Singh N. Metastases to the ovary arising from endometrial, cervical and fallopian tube cancer: recent advances. Histopathology. 2020;76(1):37\u201351.","journal-title":"Histopathology"},{"issue":"2","key":"1316_CR28","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1002\/ijc.32907","volume":"147","author":"C Reijnen","year":"2020","unstructured":"Reijnen C, Kusters-Vandevelde HVN, Ligtenberg MJL, Bulten J, Oosterwegel M, Snijders M, et al. Molecular profiling identifies synchronous endometrial and ovarian cancers as metastatic endometrial cancers with favorable clinical outcomes. Int J Cancer. 2020;147(2):478\u201389.","journal-title":"Int J Cancer"},{"issue":"6","key":"1316_CR29","doi-asserted-by":"publisher","first-page":"djv428","DOI":"10.1093\/jnci\/djv428","volume":"108","author":"MS Anglesio","year":"2016","unstructured":"Anglesio MS, Wang YK, Maassen M, Horlings HM, Bashashati A, Senz J, et al. Synchronous endometrial and ovarian carcinomas: evidence of clonality. J Natl Cancer Inst. 2016;108(6):djv428.","journal-title":"J Natl Cancer Inst"},{"key":"1316_CR30","doi-asserted-by":"publisher","first-page":"b249","DOI":"10.1136\/bmj.b249","volume":"338","author":"A Jensen","year":"2009","unstructured":"Jensen A, Sharif H, Frederiksen K, Kjaer SK. Use of fertility drugs and risk of ovarian cancer: Danish population-based cohort study. BMJ. 2009;338:b249.","journal-title":"BMJ"},{"issue":"5","key":"1316_CR31","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1016\/j.fertnstert.2015.07.1135","volume":"104","author":"B Luke","year":"2015","unstructured":"Luke B, Brown MB, Spector LG, Missmer SA, Leach RE, Williams M, et al. Cancer in women after assisted reproductive technology. Fertil Steril. 2015;104(5):1218\u201326.","journal-title":"Fertil Steril"},{"issue":"4","key":"1316_CR32","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1016\/j.fertnstert.2008.01.073","volume":"91","author":"K Sanner","year":"2009","unstructured":"Sanner K, Conner P, Bergfeldt K, Dickman P, Sundfeldt K, Bergh T, et al. Ovarian epithelial neoplasia after hormonal infertility treatment: long-term follow-up of a historical cohort in Sweden. Fertil Steril. 2009;91(4):1152\u20138.","journal-title":"Fertil Steril"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-023-01316-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13048-023-01316-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-023-01316-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,8]],"date-time":"2023-12-08T02:04:52Z","timestamp":1702001092000},"score":1,"resource":{"primary":{"URL":"https:\/\/ovarianresearch.biomedcentral.com\/articles\/10.1186\/s13048-023-01316-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,8]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1316"],"URL":"https:\/\/doi.org\/10.1186\/s13048-023-01316-w","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,8]]},"assertion":[{"value":"25 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective study was approved by the ethics committee of the Obstetrics and Gynecology Hospital of Fudan University. The authors have no ethical conflicts to disclose. All patients signed informed consent and were counseled extensively on the advantages, disadvantages, and risks of surgery and conservative therapies.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"235"}}